Graf Akcie MDRX (Allscripts Healthcare Solutions Inc). Diskuze k akciím MDRX. Aktuální informace MDRX.

Základní informace o společnosti Allscripts Healthcare Solutions Inc (Akcie MDRX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.73B
Hodnota podniku (EV) 1.91B
Tržby 1.422B
EBITDA 126.593M
Zisk 759.349M
Růst v tržbách Q/Q -8.00 %
Růst v tržbách Y/Y -17.24 %
P/E (Cena vůči ziskům) 2.97
Forward P/E 0.63
EV/Sales 1.34
EV/EBITDA 15.08
EV/EBIT 2.52
PEG 2.36
Price/Sales 1.22
P/FCF N/A
Price/Book 1.04
Účetní hodnota na akcii 13.72
Hotovost na akcii 4.43
FCF vůči ceně -23.44 %
Počet zaměstnanců 8,400
Tržba na zaměstnance 169.265k
Profit margin 46.61 %
Operating margin -6.56 %
Gross margin 37.65 %
EBIT margin 53.28 %
EBITDA margin 8.90 %
EPS - Zisk na akcii 4.79
EPS - Kvartální růst 27.78 %
EPS - Očekávaný růst příští rok -10.00 %
Return on assets 26.47 %
Return on equity 51.08 %
ROIC 23.45 %
ROCE 38.96 %
Dluhy/Equity 0.75
Čistý dluh/EBITDA 6.02
Current ratio 1.41
Quick Ratio 1.41
Volatilita 2.60
Beta 0.97
RSI 52.98
Cílová cena analytiků 12
Známka akcie (dle analytiků) 2.64
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 125.011M
Procento shortovaných akcií 21.71 %
Short ratio 8.01 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk 0.00 %
Obchodovaná od 1999
Země United States

Finanční výsledky akcie MDRX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,771.677$1,749.962$1,497.708$1,386.069$1,386.393$1,377.873
Cost Of Goods Sold$1,058.097$1,025.419$864.909$784.77$805.828$831.889
Gross Profit$713.58$724.543$632.799$601.299$580.565$545.984
Research And Development Expenses$254.509$268.409$202.282$178.534$184.791$192.821
SG&A Expenses$419.774$450.967$400.688$334.521$339.175$358.681
Other Operating Income Or Expenses$-10.837$-58.166-$-4.65$-1.544$-2.39
Operating Expenses$1,796.133$1,843.014$1,485.224$1,318.359$1,354.51$1,417.061
Operating Income$-24.456$-93.052$12.484$67.71$31.883$-39.188
Total Non-Operating Income/Expense$-182.06$106.19$-202.521$-36.15$-31.313$-28.929
Pre-Tax Income$-206.516$13.138$-190.037$31.56$0.57$-68.117
Income Taxes$-23.914$0.469$-5.514$0.309$2.626$-1.664
Income After Taxes$-182.602$12.669$-184.523$31.251$-2.056$-66.453
Other Income------
Income From Continuous Operations$-182.602$12.669$-184.523$31.251$-2.056$-66.453
Income From Discontinued Operations-$395.138$30.348$-28.221--
Net Income$-182.178$363.74$-196.459$-25.652$-2.226$-66.453
EBITDA$230.884$112.76$169.812$204.038$192.894$135.075
EBIT$-24.456$-93.052$12.484$67.71$31.883$-39.188
Basic Shares Outstanding166176181186185180
Shares Outstanding166179181186185180
Basic EPS$-1.10$2.07$-1.09$-0.14$-0.01$-0.37
EPS - Earnings Per Share$-1.10$2.04$-1.09$-0.14$-0.01$-0.37
# 2020 2019 2018 2017 2016 2015
Current Ratio0.69491.07680.96350.90591.04950.9344
Long-term Debt / Capital0.30010.29060.43930.50610.30170.2957
Debt/Equity Ratio0.71230.42240.80851.04570.44090.4413
Gross Margin40.277141.403442.251243.381641.875939.6251
Operating Margin-1.3804-5.31740.83354.8852.2997-2.8441
EBIT Margin-1.3804-5.31740.83354.8852.2997-2.8441
EBITDA Margin13.03196.443611.338114.720613.91349.8031
Pre-Tax Profit Margin-11.65650.7508-12.68852.27690.0411-4.9436
Net Profit Margin-10.282820.7856-13.1173-1.8507-0.1606-4.8229
Asset Turnover0.55270.550.35410.36170.51690.5591
Inventory Turnover Ratio------
Receiveable Turnover3.85363.76123.04073.42094.22874.1549
Days Sales In Receivables94.717797.0429120.0397106.695886.314487.8478
ROE - Return On Equity-14.20820.8016-15.90622.4545-0.1449-5.1746
Return On Tangible Equity40.4909-5.645832.4723-2.24461.3620.7738
ROA - Return On Assets-5.69610.3982-4.36210.8155-0.0767-2.6966
ROI - Return On Investment-9.94460.5686-8.91781.2123-0.1012-3.6444
Book Value Per Share7.91019.23026.41527.05347.49617.1161
Operating Cash Flow Per Share-0.1022-1.16490.10040.30160.56770.118
Free Cash Flow Per Share-0.0764-1.1068-0.1003-0.00070.57520.4015